COMPASS Pathways plc (ticker: CMPS) recently announced that its innovative therapy Comp360 psilocybin for treatment-resistant depression has successfully achieved the primary endpoint in the second pivotal Phase 3 clinical trial.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This groundbreaking development marks a solid step forward in validating the safety and efficacy of this therapy, bringing new hope to millions of patients worldwide suffering from treatment-resistant depression.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Spot gold surpasses $3,910 per ounce, rising 0.83% intraday
智通财经•2026/11/13 04:46

Spot platinum breaks through $1,540/oz, up 1.37% intraday
智通财经•2026/11/13 03:46
Crypto prices
MoreBitcoin
BTC
$68,489.33
-6.91%
Ethereum
ETH
$1,915.51
-6.29%
Tether USDt
USDT
$0.9990
+0.02%
BNB
BNB
$633.32
-5.96%
USDC
USDC
$0.9998
-0.00%
XRP
XRP
$1.01
-2.85%
Solana
SOL
$78.55
-5.13%
TRON
TRX
$0.3109
-1.92%
Hyperliquid
HYPE
$70.8
-1.04%
Zcash
ZEC
$904.33
-7.65%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now